Table 2 Availability of guidelines and medicines for prevention and management of PPH at the point of care
Items available in the delivery room (%) | Facility Type | |||
|---|---|---|---|---|
District Hospitals n = 40 | Provincial, Regional & Specialty Hospitals n = 37 | p-value | Private Hospitals, n = 10 | |
Guidelines for emergency obstetric and newborn care | 19 (47.5%) | 16 (43.2%) | 0.369 | 5 (50.0%) |
Intravenous solutions: Ringers lactate, D5%NS, or NS infusion | 35 (87.5%) | 34 (91.9%) | 0.376 | 9 (90.0%) |
Injectable oxytocin | 36 (90.0%) | 33 (89.2%) | 0.261 | 10 (100.0%) |
Misoprostol | 21 (52.5%) | 21 (56.8%) | 0.799 | 10 (100.0%) |
Injectable ergometrine/methergine | 24 (60.0%) | 24 (64.9%) | 0.457 | 8 (80.0%) |